If you or somebody you know is addicted to drugs, you are likely aware that different drugs have different effects on the body and mind.
With that said, does the substance that you are addicted to determine the probability of achieving success from a drug treatment program?
We will review some common substances and explain to you what some different approaches are when it comes to the likelihood of completing the program with minimal odds of relapse.
For heroin users, the rate of success differs.
There are a select number of medications that help with a person’s heroin addiction.
For example, buprenorphine assists in combating drug urgencies while the body is in a withdrawal phase.
Methadone is a combatant to opioids that are made to last a long time in a person’s body, taken by the day by patients that cannot handle other medications.
And then we have naltrexone, an opioid combatant that is a non-sedative. All of these are likely taken by patients while going through outpatient drug treatment NJ.
Studies have proven that buprenorphine and methadone guarantee a drug treatment success rate of about 73 percent among test subjects. After the start of these procedures, patients would find taking these medications less frequently was just as helpful.
Of all the treatment programs for heroin, the program with the highest success rate for these cases is the inpatient program.
There are currently no drugs that are approved as of this writing for the treatment of cocaine abuse by the FDA.
However, that just might change at some point in the future.
One medication that can treat alcoholism is disulfiram, which can also treat cocaine addiction, but the science community has not understood how this yet works, and different variances in the gene responsible for encoding DBH enzymes seem to play a role in whether or not disulfiram will be useful.
There is also a cocaine vaccine that has been created to produce antibodies that fight the effects of cocaine. During early tests of this new vaccine, only about 40 percent of all subjects have achieved antibody levels that have only lasted for as long as 2 months.
Of all the treatment programs for heroin, the program with the highest success rate for these cases is the intensive outpatient drug treatment NJ.
Rehab therapies for alcoholics like Alcoholics Anonymous are known to have staggering drop-out rate within the first year of the program.
This is according to scientific studies. However, when participating in AA with another type of therapy, these subjects were found to stay sober for longer.
Another study revealed that 2 of every 3 patients have attended at least AA meetings in their first year of sobriety after a follow up of 16 years. This has proven that therapy based treatments are most helpful in people who are addicted to alcohol.
As alcoholics decide between outpatient and inpatient treatment plans, a number of factors are to be considered. Inpatient programs work best for patients who suffer from mental illness, anxiety, psychosis, and delirium tremens. Outpatient programs work best for people will milder symptoms, and cost far less than inpatient programs.
Outpatient programs allow the participant to still attend work, college classes, and other activities, while inpatient programs require the patient to live in a facility or secluded community. Pick the program that works the best for you, your addiction, your budget, and your family.
Feel free to also try different ones until you have one that you are most comfortable with. Drug rehab, no matter what kind, is ultimately worth it.
Dr. Cidambi is a leader in addiction treatment and innovator of safe and effective ambulatory (outpatient) detoxification level of care for alcohol, benzodiazepines, opiates, and suboxone. Prior to founding the Center for Network Therapy, she completed her residency in Psychiatry at Maimonides Medical Center in Brooklyn and an Addiction Medicine Fellowship at NYU/Bellevue Hospital in New York. Due to the successful detoxification program, Dr. Cidambi was featured frequently by media outlets, including NPR, CBS, NY Times, and Wall Street Journal.